The FDA just approved a 'smart' pill that can track if you're taking your medication
The Food and Drug Administration just approved its first-ever pill containing electronic tracking sensors. The anti-psychotic drug Abilify MyCite, which treats bipolar disorder, schizophrenia, and depressive disorders, uses an electronic signal to record whether or not a patient ingested the pill, Gizmodo reported Tuesday.
When it touches stomach acid, the pill generates an electronic signal, which can be used to send data to medical professionals via a smartphone app and a Bluetooth signal. Sending data requires patients to first sign a consent form allowing their data to be shared with their doctors — as well as up to four selected friends and family members — and also wear a patch on their left rib cage that would transmit the information.
The New York Times notes, however, that patients can block data recipients whenever they choose to. That is potentially problematic, Dr. Jeffrey Lieberman, chairman of psychiatry at Columbia University and New York Presbyterian hospital, told the Times: "There's an irony in it being given to people with mental orders that can include delusions. It's like a biomedical Big Brother."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While patients prone to paranoia may see malicious intent in electronic tracking of drug ingestion, there are significant benefits to being able to track whether or not patients are taking their medication. Studies have shown that people usually take only half of their prescribed doses when they are self-administering medication, and a 2013 study estimated that people not taking their pills properly costs the U.S. between $100 billion and $289 billion a year and leads to 125,000 deaths annually.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
'The House under GOP rule has become a hostile workplace'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
The Shohei Ohtani gambling scandal is about more than bad bets
In The Spotlight The firestorm surrounding one of baseball's biggest stars threatens to upend a generational legacy and professional sports at large
By Rafi Schwartz, The Week US Published
-
Feds raid Diddy homes in alleged sex trafficking case
Speed Read Homeland Security raided the properties of hip hop mogul Sean "Diddy" Combs
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published
-
Immigration helped the US economy outpace peers
speed read The U.S. economy grew at an annualized rate of 3.2% last quarter
By Peter Weber, The Week US Published
-
4-day workweek gets boost from UK study
Speed Read Following a six-month trial, the majority of participating British companies are still using the truncated schedule
By Peter Weber, The Week US Published
-
US sues to block Kroger-Albertsons merger
Speed Read The Federal Trade Commission sued to block the $24.6 billion merger between the grocery giants
By Peter Weber, The Week US Published
-
Nvidia sees historic stock rise on AI chips success
Speed Read U.S. chipmaker Nvidia achieved the biggest one-day increase in value of any company in history
By Peter Weber, The Week US Published
-
New York may seize Trump's assets for $450M penalty
Speed Read The former president likely owes $600 million from two civil judgments in New York
By Peter Weber, The Week US Published